About: A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 07 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'abril de 2020 (ast) im April 2020 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 07 April 2020 (en) наукова стаття, опублікована 7 квітня 2020 (uk)
publication date	wds:Q91665341-95CBF6B2-94AE-4CCC-BC4E-B6C12E8BC630
publication date	2020-04-07 00:00:00Z (xsd:dateTime)
cites work	wds:Q91665341-1E3C8186-85ED-4777-AF0E-1A310E322058 wds:Q91665341-77047989-F6C9-449E-8DE3-C3F56DBE6FC1 wds:Q91665341-7DBCA649-3B61-478E-8880-49E5C370565F wds:Q91665341-8491A66F-A4CF-4B12-BF30-21C0432DF42E wds:Q91665341-99BA3EE5-7E80-48E0-A2CD-F55CE68700B2 wds:Q91665341-A02EA289-9230-4EDF-9B4D-72BA4B736EFC wds:Q91665341-B4269011-3CDB-4B85-B6AC-CA9AD735FCA7 wds:Q91665341-C79E9C7F-7E8F-4E3C-ABE5-CD04DE03BF55
cites work	The in vitro effect of hydroxychloroquine on skin morphology in psoriasis Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools The COVID‐19 epidemic COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action
rdfs:label	A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (en) A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (nl)
skos:prefLabel	A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (en) A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (nl)
name	A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (en) A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (nl)
author	wds:Q91665341-AB40BE48-A57D-431F-8D35-902B7973B97C wds:Q91665341-E932ABE1-C514-41FB-9768-027DFCD2BA35
author	Ömer Kutlu Ahmet Metin
title	wds:Q91665341-756CF456-982A-42EC-9B3F-A39FC3C87E58
title	A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? (en)
page(s)	wds:Q91665341-035F52BE-EF49-4A35-9D40-9228FDEFB014
page(s)	e13383
instance of	wds:Q91665341-A39E1517-C1D0-4791-AC23-FA6E3EA8513F
instance of	scholarly article
main subject	wds:Q91665341-05032EF0-3192-406A-8A51-0A350A21A55A wds:Q91665341-59E79029-9D87-4E32-832A-CA3F5174F506 wds:Q91665341-6D935FA2-0618-463E-B904-5EFBC9F07E5C wds:Q91665341-73F1E5CF-42D0-403C-8FE8-8262C8D1E3DB wds:Q91665341-82BBF23C-901C-4726-96CC-3EA4AB4C5B21 wds:Q91665341-D356EE39-986C-4D3E-9822-8939D5FC2323
main subject	SARS-CoV-2 COVID-19 pandemic hydroxychloroquine pandemic COVID-19 mortality oseltamivir
PubMed ID	wds:Q91665341-8560F248-1450-49BB-8686-D9FB28293A85
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32259878
PubMed ID	32259878
published in	wds:Q91665341-257D1F71-D08F-4F6C-8A6A-90A3DEF9220B
published in	Dermatologic Therapy
DOI	wds:Q91665341-382565CA-3B3E-40E2-A012-FB920CA7B78E
DOI	http://dx.doi.org/10.1111/DTH.13383
DOI	10.1111/DTH.13383
Dimensions Publication ID	wds:Q91665341-51D3E400-959B-4625-BEB7-E37A39A633AE
Dimensions Publication ID	1126183467
PMCID	wds:Q91665341-99AAE068-01AF-4343-A1F2-E0F710F7AEE1
PMCID	7235511
COVIDWHO ID	wds:Q91665341-E6A46AD4-4F98-4F8D-ACB2-6BB0438FE708
COVIDWHO ID	covidwho-38637
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91665341
is cites work of	Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice
is cites work of	wds:Q99202044-C0141D8F-A7EF-483C-84F4-20E8145EA019 wds:Q97645906-AB1A7A9B-9F78-4CC9-8DB2-FB9B15043DB3 wds:Q95633060-FA5C076B-443A-416F-864E-AD6D948CDF10

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software